EGFR and breast cancer: Both molecules are associated with an inhibition of the growth of breast cancer MDA-MB-231 cells by disrupting the positive regulatory loop with epidermal growth factor receptor (EGFR), which promotes malignant growth of TNBC cells [97,98].